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Fructose consumption has markedly increased over the past
decades. This intake may increase the urinary excretion of
calcium, oxalate, uric acid, and other factors associated with
kidney stone risk. We prospectively examined the
relationship between fructose intake and incident kidney
stones in the Nurses’ Health Study I (NHS I) (93 730 older
women), the Nurses’ Health Study II (NHS II) (101 824
younger women), and the Health Professionals Follow-up
Study (45 984 men). Food frequency questionnaires were
used to assess free fructose and sucrose intake every 4 years.
Total-fructose intake was calculated as free fructose plus half
the intake of sucrose, and expressed as percentage of total
energy. Cox proportional hazard regressions were adjusted
for age, body mass index (BMI), thiazide use, caloric intake,
and other dietary factors. We documented 4902 incident
kidney stones during a combined 48 years of follow-up.
The multivariate relative risks of kidney stones significantly
increased for participants in the highest compared to the
lowest quintile of total-fructose intake for all three study
groups. Free-fructose intake was also associated with
increased risk. Non-fructose carbohydrates were not
associated with increased risk in any cohort. Our study
suggests that fructose intake is independently associated
with an increased risk of incident kidney stones.
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Kidney stones are common, costly, and painful. The lifetime
prevalence of symptomatic nephrolithiasis is approximately
10% in men and 5% in women,1–3 and more than $2 billion is
spent on treatment each year.4 Diet plays an important role in
the pathogenesis of stone disease, and changes in dietary
habits likely contributed to the substantial increase in
nephrolithiasis observed over the past several decades.5
Fructose intake increased approximately 2000% over 30
years after the widespread introduction of high-fructose corn
syrup in 1967,6 and fructose may increase the urinary
excretion of calcium and oxalate, both of which are
important risk factors for calcium nephrolithiasis. Rats fed
high-fructose diets have higher urinary calcium excretion and
an eightfold increase in nephrocalcinosis compared to rats
fed high-starch diets.7,8 A study of calcium and phosphorus
balance in healthy men consuming controlled diets demon-
strated higher urinary losses of calcium as a percentage
of calcium intake on a high-fructose versus high-starch diet.9
In another study on human, intravenous infusion of fructose
increased urinary oxalate excretion by 60% compared to
glucose infusion.10 Of note, the effect of fructose intake on
calcium balance and urinary oxalate excretion may vary
depending on the intake of magnesium and vitamin B6,
respectively.7–9,11
Fructose intake may also increase insulin resistance, which
is associated with low urinary pH,12 a major risk factor for
uric acid kidney stones. In addition, fructose is the only
carbohydrate known to increase the production of uric
acid.13–16 Fructose infusion increases urinary uric acid,14
which may be a risk factor for kidney stone formation.17,18
To examine the relationship between fructose intake and
the incidence of kidney stones, we conducted a prospective
study of three large cohorts: the Nurses’ Health Study I (NHS
I), the Nurses’ Health Study II (NHS II), and the Health
Professionals Follow-up Study (HPFS).
RESULTS
Over a combined 48 years of follow-up, we documented 4902
new symptomatic kidney stones in the three cohorts. In
NHS I (older women), NHS II (younger women), and HPFS
(men), there were 1711, 1564, and 1627 incident kidney
stones, respectively.
Baseline characteristics by quintile of total-fructose intake
are displayed in Table 1. There was a wide range of total-
fructose intake in the study population: median intake in the
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highest quintile was approximately 2.5 times that in the
lowest. Age, prevalence of hypertension, and frequency of
thiazide use were similar across quintiles of total-fructose
intake. NHS II and HPFS participants in the highest quintile
of total-fructose intake had lower body mass indices (BMIs)
than those in the lowest quintile. In all three cohorts,
participants in the highest quintile of total-fructose intake
were less likely to have diabetes than participants in the
lowest quintile.
Because the association between free-fructose intake and
kidney stone risk persisted even after adjusting for sucrose,
we report separate results for both free and total fructose.
Free-fructose intake was associated with an increased risk of
incident kidney stones (Table 2) in both age-adjusted and
multivariate regression models. After adjustment for age,
BMI, total energy intake, use of thiazide diuretics, fluid
intake, caffeine, alcohol use, calcium supplement use,
percentage of energy from non-fructose carbohydrate,
percentage of energy from total protein, and intake of
calcium, oxalate, potassium, and sodium, the relative risk for
older women in the highest as compared to lowest quintile of
free-fructose intake was 1.29 (95% confidence interval
1.08–1.53; P for trend o0.001), the relative risk for younger
women was 1.22 (95% confidence interval 1.01–1.47; P for
trend 0.01), and the relative risk for men was 1.28 (95%
confidence interval 1.06–1.55; P for trend 0.002).
Total-fructose intake was also associated with an increased
risk of incident kidney stones (Table 3). The multivariate
relative risk for older women in the highest as compared to
lowest quintile of total-fructose intake was 1.37 (95%
confidence interval 1.13–1.65; P for trend o0.001), the
multivariate relative risk for younger women was 1.35 (95%
confidence interval 1.10–1.66; P for trend 0.004), and the
multivariate relative risk for men was 1.27 (95% confidence
interval 1.04–1.54; P for trend 0.006).
The intake of non-fructose carbohydrates was not
associated with an increased risk of incident kidney stones
in any cohort. Exclusion of participants with diabetes at
baseline or during follow-up did not change the results, nor
did adjustment for hypertension. When fructose was
analyzed in absolute amounts, rather than as percentage of
total energy, the results were similar. Finally, we performed
analyses stratified by median magnesium intake, median
vitamin B6 intake, and dichotomized BMI (BMIo25 versus
BMIX25). The relation between fructose intake (free or
total) and risk did not vary by magnesium, vitamin B6, or
BMI.
DISCUSSION
In this large prospective study of three distinct cohorts,
fructose intake was positively associated with the risk of
incident kidney stones. This relation was independent of
other dietary factors, age, body size, and the use of thiazide
diuretics. The intake of non-fructose carbohydrates was not
associated with increased risk.
The mechanisms underlying the relation between fructose
and stone risk are unknown, but may be related to the effect
of fructose intake on urine composition. Fructose intake may
alter calcium metabolism, particularly in the setting of low
magnesium intake. Rats fed a magnesium-deficient, fructose-
rich diet for 4 weeks had eightfold greater levels of
nephrocalcinosis than rats with magnesium-deficient diets
with energy derived from glucose or starch.8 The nephro-
calcinosis in the magnesium-deficient fructose diet was
accompanied by hypercalciuria and consisted of calcium
phosphate, rather than calcium oxalate, deposition.7 The
latter is an intriguing finding given that the initial phase of
calcium oxalate stones may be interstitial deposits of calcium
phosphate.19 More recently, 11 healthy men consumed
controlled diets with low or high magnesium content (170
versus 370 mg per 2500 kcal per day) and with starch versus
fructose at 20% of energy intake.9 The high-fructose diet,
especially in conjunction with lower dietary magnesium,
resulted in higher urinary losses of calcium as a percentage of
calcium intake (22.7 versus 19.9%; Po0.01). The excretion of
urinary calcium was similar on high- compared to low-
fructose diets, but the high-fructose diet contained 12% less
dietary calcium. Of note, in our study, we did not observe
that the stone risk associated with fructose was greater in
those with lower intake of magnesium.
Fructose intake may also increase urinary excretion of
oxalate, an important risk factor for calcium oxalate
nephrolithiasis. Carbohydrates, along with amino acids,
provide the majority of the carbon for glyoxylate and oxalate
synthesis, and fructose may be an important dietary sugar
influencing the production of oxalate.20 Data supporting this
Table 1 | Age-standardized baseline characteristics according to quintile of total-fructose intake in older women (NHS I),
younger women (NHS II), and men (HPFS)
NHS I NHS II HPFS
Quintile of total-fructose intake Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5
Median total fructose (% of energy) 5.7 8.1 9.7 11.5 15.2 5.7 7.5 9.1 10.9 14.4 5.6 7.8 9.3 11.0 13.8
Age (years) 46.3 46.3 46.4 46.4 46.0 36.4 36.4 36.2 36.0 35.6 54.1 54.5 54.5 54.7 54.7
BMI (kg m2) 24.4 24.3 24.2 24.2 24.4 25.4 25.0 24.5 24.1 24.0 25.2 25.1 24.8 24.7 24.7
Hypertension (%) 15 15 15 16 17 7 6 6 5 7 24 22 21 20 22
Diabetes (%) 3 2 2 2 1 1 1 o1 o1 o1 6 4 2 2 2
Thiazide use (%) 10 10 9 10 11 2 2 2 2 2 10 9 9 9 9
BMI, body mass index; HPFS, the Health Professionals Follow-up Study; NHS I, the Nurses’ Health Study I; NHS II, the Nurses’ Health Study II.
Values are expressed as means unless otherwise noted.
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contention are sparse but provocative. Experiments using
isolated rat hepatocytes demonstrate that the addition of
fructose stimulates oxalate production.21,22 In a study of
seven healthy individuals, intravenous infusion of approxi-
mately 35 g of fructose increased urinary oxalate excretion by
60% compared to glucose infusion.10 Other experiments have
not shown higher urinary oxalate levels after fructose
administration.23 Of interest, some animal data suggest that
Table 2 | Quintiles of free-fructose intake and the RR of incident kidney stones in older women (NHS I), younger women (NHS
II), and men (HPFS)
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 P for trend
NHS I
Free fructose (% of energy) o3.5 3.5–4.5 4.6–5.5 5.6–6.9 46.9
Cases of new stones 347 311 331 333 389
Person-years 317 700 317 859 317 653 317 762 317 587
Age-adjusted RR (95% CI) 1.0 (ref) 0.91 (0.78–1.06) 0.98 (0.84–1.14) 0.99 (0.85–1.15) 1.16 (1.01–1.35) 0.003
Multivariate RRa (95% CI) 1.0 (ref) 0.98 (0.83–1.14) 1.10 (0.93–1.29) 1.13 (0.96–1.33) 1.29 (1.08–1.53) o0.001
NHS II
Free fructose (% of energy) o3.1 3.1–4.0 4.1–5.0 5.1–6.5 46.5
Cases of new stones 303 288 265 301 407
Person-years 169 569 169 486 169 762 169 425 169 343
Age-adjusted RR (95% CI) 1.0 (ref) 0.96 (0.82–1.13) 0.88 (0.74–1.03) 0.99 (0.85–1.16) 1.33 (1.15–1.55) o0.001
Multivariate RRa (95% CI) 1.0 (ref) 1.00 (0.85–1.18) 0.93 (0.78–1.10) 1.03 (0.86–1.23) 1.22 (1.01–1.47) 0.01
HPFS
Free fructose (% of energy) o3.4 3.4–4.3 4.4–5.3 5.4–6.8 46.8
Cases of new stones 324 301 321 338 343
Person-years 107 033 107 069 107 130 107 226 107 010
Age-adjusted RR (95% CI) 1.0 (ref) 0.95 (0.81–1.11) 1.02 (0.88–1.19) 1.09 (0.93–1.27) 1.10 (0.95–1.29) 0.06
Multivariate RRa (95% CI) 1.0 (ref) 1.00 (0.85–1.17) 1.10 (0.94–1.30) 1.21 (1.02–1.44) 1.28 (1.06–1.55) 0.002
CI, confidence interval; HPFS, the Health Professionals Follow-up Study; NHS I, the Nurses’ Health Study I; NHS II, the Nurses’ Health Study II; RR, relative risk.
For illustrative purposes, quintile cut points for free fructose were derived from responses to the 1994 (NHS I and HPFS) and 1995 (NHS II) dietary questionnaires.
aThe multivariate model includes age, body mass index, total energy intake, use of thiazide diuretics (yes or no), fluid intake (in quintiles), caffeine (in quintiles), alcohol use
(seven categories), calcium supplement use (four categories), percentage of energy from non-fructose carbohydrate (quintiles), percentage of energy from total protein
(quintiles), and intake of calcium, oxalate, potassium, and sodium (all in quintiles).
Table 3 | Quintiles of total-fructose intake and the RR of incident kidney stones in older women (NHS I), younger women (NHS
II), and men (HPFS)
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 P for trend
NHS I
Total fructose (% of energy) o7.2 7.2–8.9 9.0–10.5 10.6–12.6 412.6
Cases of new stones 310 292 355 361 393
Person-years 317 729 317 863 317 674 317 661 317 634
Age-adjusted RR (95% CI) 1.0 (ref) 0.96 (0.82–1.12) 1.17 (1.01–1.36) 1.21 (1.04–1.40) 1.32 (1.14–1.53) o0.001
Multivariate RRa (95% CI) 1.0 (ref) 0.99 (0.84–1.17) 1.23 (1.05–1.46) 1.28 (1.08–1.52) 1.37 (1.13–1.65) o0.001
NHS II
Total fructose (% of energy) o6.7 6.7–8.2 8.3–9.8 9.9–12.2 412.2
Cases of new stones 260 287 289 309 419
Person-years 169 527 169 540 169 528 169 506 169 486
Age-adjusted RR (95% CI) 1.0 (ref) 1.10 (0.93–1.30) 1.11 (0.94–1.31) 1.18 (1.00–1.39) 1.58 (1.36–1.85) o0.001
Multivariate RRa (95% CI) 1.0 (ref) 1.10 (0.93–1.31) 1.11 (0.92–1.33) 1.15 (0.95–1.38) 1.35 (1.10–1.66) 0.004
HPFS
Total fructose (% of energy) o6.9 6.9–8.5 8.6–10.0 10.1–12.1 412.1
Cases of new stones 310 299 324 328 366
Person-years 107 167 107 146 107 186 107 230 106 740
Age-adjusted RR (95% CI) 1.0 (ref) 0.99 (0.84–1.16) 1.09 (0.93–1.28) 1.12 (0.96–1.31) 1.25 (1.08–1.46) o0.001
Multivariate RRa (95% CI) 1.0 (ref) 0.98 (0.83–1.15) 1.07 (0.90–1.27) 1.11 (0.93–1.33) 1.27 (1.04–1.54) 0.006
CI, confidence interval; HPFS, the Health Professionals Follow-up Study; NHS I, the Nurses’ Health Study I; NHS II, the Nurses’ Health Study II; RR, relative risk.
For illustrative purposes, quintile cut points for total fructose were derived from responses to the 1994 (NHS I and HPFS) and 1995 (NHS II) dietary questionnaires.
aThe multivariate model includes age, body mass index, total energy intake, use of thiazide diuretics (yes or no), fluid intake (in quintiles), caffeine (in quintiles), alcohol use
(seven categories), calcium supplement use (four categories), percentage of energy from non-fructose carbohydrate (quintiles), percentage of energy from total protein
(quintiles), and intake of calcium, oxalate, potassium, and sodium (all in quintiles).
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the effect of fructose intake on urinary oxalate is more
pronounced on diets deficient in vitamin B6.11 However, in
this study, we did not observe that the stone risk associated
with fructose was greater in those with lower intake of
vitamin B6.
Insulin resistance is likely an important risk factor for uric
acid kidney stones and may mediate the relation between
fructose intake and kidney stone risk. Data on animals
demonstrate that high levels of fructose intake decrease
insulin sensitivity.24 For example, rats fed a diet containing
35% of energy as fructose for 4 weeks developed reduced
insulin sensitivity and whole-body glucose disposal com-
pared to rats fed a comparable amount of starch.25 Insulin
resistance may manifest in the kidney as a defect in
ammonium production,26 and experiments on humans
utilizing hyperinsulinemic euglycemic clamp confirm that
insulin resistance is associated with low urinary pH,12 a
major risk factor for uric acid nephrolithiasis.17 Although the
majority of incident kidney stones in this study likely were
calcium oxalate, it is possible that fructose intake was
associated with a very high risk of uric acid stone formation
in a relatively small proportion of participants. It should be
noted, however, that baseline characteristics in our study
associated with insulin resistance and the development of
kidney stones (i.e., higher BMI and higher prevalence of type
II diabetes27,28) were not positively associated with fructose
intake. In addition, data on humans linking fructose intake to
impaired insulin sensitivity are inconsistent.24
A final possibility is that fructose increases stone risk by
influencing uric acid metabolism. Higher urinary uric acid
levels are a putative risk factor for kidney stone forma-
tion,17,18 and fructose, unlike other carbohydrates, increases
the production of uric acid.29 Hepatic fructose phosphoryla-
tion depletes phosphate stores, inhibits the regeneration of
ATP, and results in high levels of AMP that are subsequently
metabolized to uric acid.30 Fructose infusion increases both
plasma and urinary concentrations of uric acid.14 An
important caveat to any proposed connection between
fructose, uric acid, and kidney stones is that 24-h urinary
uric acid levels in a subset of NHS I, NHS II, and HPFS
participants were not associated with stone risk.31
Our data highlight a particular complexity of formulating
specific dietary advice to reduce the risk of kidney stone
recurrence. In general, diets are isocaloric: if an individual
reduces the intake of certain foods, he or she will increase the
intake of others to maintain constant energy intake. As a
result, advising patients with recurrent stone disease to
consume less of one dietary factor may lead to the
consumption of another factor that increases the risk of
stone formation. For example, a stone former with
hypercalciuria and a high protein catabolic rate may be
advised to reduce their intake of animal protein. If this
individual reduces their consumption of animal protein but
increases their consumption of free fructose or sucrose as a
result, stone risk may remain constant (or even increase).
Therefore, it is crucial for the clinician to gauge the impact of
any dietary recommendation with follow-up 24-h urine
collections.
An important limitation to this study is that we do not
have stone composition reports or 24-h urine collections
from all the stone formers in our cohorts. Thus, we were
unable to determine if fructose intake increases the risk of
certain stone types, such as uric acid, but not others. The
generalizability of our study is also limited. Only a small
proportion of our study population is non-white, and we do
not have data on stone formation in men aged less than 40
years. Finally, we had limited statistical power to evaluate the
relationship between fructose intake and stone risk in
individuals consuming diets very low in magnesium or
vitamin B6.
In conclusion, our prospective data indicate that the
consumption of fructose is independently associated with an
increased risk of incident kidney stones. Further research is
needed to delineate the effect of fructose intake on the
urinary excretion of calcium and to determine the role of
dietary fructose in the endogenous generation of oxalate.
Clinicians caring for patients with stone disease should
ensure that individuals who decrease their intake of protein
or fat do not subsequently increase their consumption of
fructose-rich foods.
MATERIALS AND METHODS
Study population
Nurses’ Health Study I. In 1976, 121 700 female registered nurses
between the age of 30 and 55 years enrolled in NHS I by completing
and returning an initial questionnaire that provided detailed
information on diet, medical history, and medications. This cohort,
similar to NHS II and HPFS, was followed by biennial mailed
questionnaires, which included inquiries about newly diagnosed
diseases such as kidney stones. Since we first asked NHS I
participants about their lifetime history of kidney stones in 1992,
this analysis was limited to women who answered questionnaires in
1992 or later. For this study, we started follow-up in 1980, since
before that date we lacked information on diet. After excluding
women with kidney stones before 1980, our study population
included 93 730 women.
Nurses’ Health Study II. In 1989, 116 671 female registered
nurses between the age of 25 and 42 years enrolled in NHS II by
completing and returning an initial questionnaire. Dietary informa-
tion was first collected from this cohort in 1991. We limited the
analysis to women who completed at least one dietary questionnaire
and excluded participants with a history of kidney stones before
1991. A total of 101 824 women remained in the study group.
Health Professionals Follow-up Study. In 1986, 51 529 male
dentists, optometrists, osteopaths, pharmacists, podiatrists, and
veterinarians between the age of 40 and 75 years enrolled in HPFS by
completing and returning an initial questionnaire. We limited the
analysis to men who completed at least one dietary questionnaire
and excluded participants with a history of kidney stones before
1986. A total of 45 984 men remained in the study group.
Assessment of dietary intake
To assess dietary intake, we used a semiquantitative food-frequency
questionnaire (FFQ) that asked about the average use of more than
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130 foods and beverages during the previous year. The baseline
dietary questionnaires were completed in 1986 (HPFS), 1980 (NHS
I), and 1991 (NHS II), and were updated every 4 years.
Intake of fructose and other dietary factors was computed from
the reported frequency of consumption of each specified unit of
food and, with the exception of oxalate, from United States
Department of Agriculture data on the content of the relevant
nutrient in specified portions. The oxalate content of the majority of
foods on the FFQ, as well as frequently consumed write-in foods,
was measured by capillary electrophoresis in the laboratory of Dr
Ross Holmes.32 The intake of supplements (such as calcium and
vitamin C) in multivitamin or isolated form was determined by the
brand, type, and frequency of reported use.
Fructose is consumed as a monosaccharide or as part of sucrose,
a disaccharide that is hydrolyzed to glucose and fructose in the small
intestine. Therefore, total-fructose intake is equal to the intake of
free fructose (i.e., fructose consumed as a monosaccharide) plus half
the intake of sucrose. The main sources of free fructose in each
cohort were sugar-sweetened soft drinks, fruit juice, and fruit. For
example, at baseline in HPFS, consumption of the following foods
accounted for 57.2% of free-fructose intake: sugar-sweetened soft
drinks (15.5%), apples (11.6%), orange juice (9.3%), bananas
(6.9%), apple juice (4.8%), raisins (4.7%), and fruit punch (4.4%).
The main sources of sucrose varied by cohort and FFQ year, but
generally included table sugar, sugar-sweetened soft drinks, fruit
juices, fruit punch, cake, ice cream, cold cereal, milk chocolate,
canned peaches, and fruit. For example, at baseline in HPFS,
consumption of the following foods accounted for 50.6% of sucrose
intake: table sugar (7.7%), sugar-sweetened soft drinks (7.5%),
orange juice (7.5%), cake (of various types, totaling 7.4%), ice
cream (5.7%), cold cereal (4.1%), milk chocolate (3.7%), canned
peaches (3.7%), and oranges (3.3%).
The reproducibility and validity of the FFQs in NHS I and HPFS
have been documented.33,34 Correlations between intake of foods
high in free fructose as measured by the FFQ and as assessed by
dietary records were 0.84 for sugar-sweetened cola, 0.55 for other
sugar-sweetened soft drinks, 0.78 for orange juice, 0.77 for apple
juice, 0.89 for other fruit juices, 0.70 for apples, 0.76 for oranges,
0.95 for bananas, and 0.59 for raisins.35
Assessment of non-dietary covariates
For each cohort, information on age, weight, and height was
obtained on the baseline questionnaire, and age and weight were
updated every 2 years. BMI was calculated as weight (kg) divided by
height (m2). In NHS I, thiazide use was determined in 1980, 1982,
and then every 6 years until 1994, when biennial updates started.
Information on thiazide diuretics was updated every 2 years in
HPFS and NHS II.
Assessment of incident kidney stones
The primary outcome was an incident kidney stone accompanied by
pain or hematuria. The participants reported on the interval
diagnosis of kidney stones every 2 years. Any study participant who
reported a new kidney stone on the biennial questionnaire was sent
an additional questionnaire to determine the date of occurrence and
the symptoms from the stone. In NHS I, we obtained medical
records from 194 women who reported a kidney stone, and 96% of
the records confirmed the diagnosis. There were 78 records that
contained a stone composition report, and 60 women (77%) had a
stone that containedX50% calcium oxalate. In NHS II, we obtained
medical records from 858 women who reported a kidney stone, and
98% of the records confirmed the diagnosis. There were 243 records
that contained a stone composition report, and 191 women (79%)
had a stone that contained X50% calcium oxalate. In HPFS, we
obtained medical records from 582 men who reported a kidney
stone, and the diagnosis was confirmed in 95%. There were 148
records that contained a stone composition report, and 127 men
(86%) had a stone that contained X50% calcium oxalate.
Statistical analysis
The study design was prospective; information on diet was collected
before the diagnosis of the kidney stone. The relative risk was used
as the measure of association between fructose intake and incident
kidney stones. Fructose intake was expressed as a percentage of total
caloric intake (i.e., as nutrient density36) and was divided into
quintiles, with the lowest quintile serving as the referent group. The
Mantel extension test was used to evaluate linear trends across
categories of intake.
Dietary exposures were updated every 4 years. We allocated
person-months of follow-up according to exposure status at the
start of each follow-up period. If complete information on diet was
missing at the start of a time period, the subject was excluded for
that time period. For NHS I, person-months of follow-up were
counted from the date of the return of the 1980 questionnaire to the
date of a kidney stone or death or to 31 May 2002, whichever came
first. For NHS II, person-months of follow-up were counted from
the date of the return of the 1991 questionnaire to the date of a
kidney stone or death or to 31 May 2001. For HPFS, person-months
of follow-up were counted from the date of the return of the 1986
questionnaire to the date of a kidney stone or death or to 31 January
2002.
We used Cox proportional hazards regression to estimate the
relative risk for incident kidney stones in all multivariate analyses.
The multivariate models simultaneously included total energy
intake, the percentage of energy derived from protein, and the
percentage of energy derived from non-fructose carbohydrates.
Therefore, the coefficients from the multivariate nutrient density
models can be interpreted as the estimated effect of substituting a
specific percentage of energy from fructose for the same percentage
of energy from fat.36 Potentially confounding variables considered
for inclusion in the multivariate models were age (continuous), BMI
(six categories), alcohol intake (seven categories), the use of thiazide
diuretics (yes or no), supplemental calcium use (four categories),
and the intake of fluid, potassium, sodium, phosphorus, magne-
sium, vitamin C, vitamin B6, phytate, vitamin D, oxalate, and
dietary calcium (quintile groups).
We calculated 95% confidence intervals for all relative risks. All
P-values are two-tailed. Data were analyzed by using SAS software,
version 9.1 (SAS Institute Inc., Cary, NC, USA). The research
protocol for this study was reviewed and approved by the
Institutional Review Board of Brigham and Women’s Hospital.
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